MA30951B1 - Medicament pour l'amelioration d'une fonction cognitive et la neuroprotection - Google Patents
Medicament pour l'amelioration d'une fonction cognitive et la neuroprotectionInfo
- Publication number
- MA30951B1 MA30951B1 MA31589A MA31589A MA30951B1 MA 30951 B1 MA30951 B1 MA 30951B1 MA 31589 A MA31589 A MA 31589A MA 31589 A MA31589 A MA 31589A MA 30951 B1 MA30951 B1 MA 30951B1
- Authority
- MA
- Morocco
- Prior art keywords
- memory
- cognitive function
- improving cognitive
- benz
- piperidin
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 230000003920 cognitive function Effects 0.000 title abstract 2
- 230000004112 neuroprotection Effects 0.000 title 1
- 208000000044 Amnesia Diseases 0.000 abstract 2
- -1 ISOXAZOLE-3-YL Chemical class 0.000 abstract 2
- 208000026139 Memory disease Diseases 0.000 abstract 2
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 230000002490 cerebral effect Effects 0.000 abstract 1
- 230000007423 decrease Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000006870 function Effects 0.000 abstract 1
- 230000006984 memory degeneration Effects 0.000 abstract 1
- 208000023060 memory loss Diseases 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 230000016273 neuron death Effects 0.000 abstract 1
- 230000000324 neuroprotective effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
L'INVENTION CONCERNE L'UTILISATION DE LA 4-CHLORO-5-{2-[4-(6-FLUORO-1,2- BENZ[D]ISOXAZOLE-3-YL)PIPÉRIDIN-1-YL]ÉTHYL-AMINO}-2-MÉTHYL-3-(2H) PYRIDAZINONE REPRÉSENTÉE PAR LA FORMULE (I) OU DES SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CELLE-CI POUR LA PRÉPARATION DE MÉDICAMENTS APPROPRIÉS POUR L'AMÉLIORATION D'UNE FONCTION COGNITIVE OU L'OBTENTION D'UN EFFET NEUROPROTECTEUR. LES MÉDICAMENTS CONTENANT LA 4-CHLORO-5-{2-[4-(6-FLUORO-1,2-BENZ[D]ISOXAZOL-3-YL)PIPÉRIDIN-1-YL]ÉTHYL-AMINO}-2-MÉTHYL-3-(2H) PYRIDAZINONE REPRÉSENTÉE PAR LA FORMULE (I) OU UN SEL THÉRAPEUTIQUEMENT ACCEPTABLE DE CELLE-CI PEUVENT ÊTRE UTILISÉS POUR LE TRAITEMENT OU LA PRÉVENTION DE LA MORT NEURONALE, DU DÉCLIN MENTAL, DE LA SCLÉROSE EN PLAQUES, DE LA MALADIE DE CREUZFELD-JACOBS, DU SYNDROME DE HUNTINGTON, DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE, DE LA MALADIE DE PARKINSON, DU TROUBLE DE LA MÉMOIRE, DE LA PERTE DE MÉMOIRE, DE L'AMNÉSIE, DE L'ACCIDENT VASCULAIRE CÉRÉBRAL OU POUR L'AMÉLIORATION DE LA FONCTION DE LA MÉMOIRE OU DE L'APTITUDE À L'APPRENTISSAGE.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0600555A HUP0600555A3 (en) | 2006-07-03 | 2006-07-03 | Use of 4-chloro-5-{2-[4-(6-fluoro-1,2-benz[d]izoxazol-3-yl)piperidin-1-yl]ethylamino}2-methyl-3(2h)-piridazinon for the production of pharmaceutical compositions for influencing cognitive functions and causing neuroprotective effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA30951B1 true MA30951B1 (fr) | 2009-12-01 |
Family
ID=89986887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA31589A MA30951B1 (fr) | 2006-07-03 | 2009-01-27 | Medicament pour l'amelioration d'une fonction cognitive et la neuroprotection |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8318743B2 (fr) |
| EP (1) | EP2049113B8 (fr) |
| JP (1) | JP5174018B2 (fr) |
| KR (1) | KR101465415B1 (fr) |
| CN (1) | CN101516373B (fr) |
| AT (1) | ATE468854T1 (fr) |
| AU (1) | AU2007270910B2 (fr) |
| BR (1) | BRPI0713395A2 (fr) |
| CA (1) | CA2656549C (fr) |
| CY (1) | CY1110741T1 (fr) |
| DE (1) | DE602007006813D1 (fr) |
| DK (1) | DK2049113T3 (fr) |
| EA (1) | EA016142B1 (fr) |
| HK (1) | HK1131032A1 (fr) |
| HR (1) | HRP20100465T1 (fr) |
| HU (1) | HUP0600555A3 (fr) |
| IL (1) | IL196315A (fr) |
| MA (1) | MA30951B1 (fr) |
| MX (1) | MX2009000243A (fr) |
| NZ (1) | NZ574596A (fr) |
| PL (1) | PL2049113T3 (fr) |
| PT (1) | PT2049113E (fr) |
| RS (1) | RS51429B (fr) |
| SI (1) | SI2049113T1 (fr) |
| WO (1) | WO2008004013A2 (fr) |
| ZA (1) | ZA200900507B (fr) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP9602763A3 (en) | 1996-10-09 | 1999-05-28 | Egyt Gyogyszervegyeszeti Gyar | 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same |
| WO2001017993A1 (fr) * | 1999-09-09 | 2001-03-15 | EGIS Gyógyszergyár Rt. | Derives d'alkypiperidi nylbenzo [d] isoxazole presentant une activite psychotrope, compositions pharmaceutiques contenant ces derniers, et procede de preparation de l'ingredient actif |
| US20030024849A1 (en) | 2001-07-26 | 2003-02-06 | Nielsen Jacob Sturich | Package for blister pack strips |
| HU225955B1 (en) * | 2001-07-26 | 2008-01-28 | Egis Gyogyszergyar Nyilvanosan | Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them |
| HU227118B1 (en) | 2001-11-13 | 2010-07-28 | Egis Gyogyszergyar Nyilvanosan | Process for the preparation of 3-{2-[4-(6-fluoro-1,2-benzizoxazol-3-yl)-1-piperidinyl]-ethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido[1,2-a]pyrimidin-4-one |
| HU227255B1 (en) * | 2002-04-26 | 2010-12-28 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Novel piperidine-alkyl-amino-pyridazine derivatives, pharmaceutical compositions containing the same and process for the preparation of the active ingredient |
-
2006
- 2006-07-03 HU HU0600555A patent/HUP0600555A3/hu unknown
-
2007
- 2007-07-03 KR KR1020097002214A patent/KR101465415B1/ko not_active IP Right Cessation
- 2007-07-03 EA EA200900088A patent/EA016142B1/ru not_active IP Right Cessation
- 2007-07-03 SI SI200730327T patent/SI2049113T1/sl unknown
- 2007-07-03 RS RSP-2010/0375A patent/RS51429B/en unknown
- 2007-07-03 DE DE602007006813T patent/DE602007006813D1/de active Active
- 2007-07-03 ZA ZA200900507A patent/ZA200900507B/xx unknown
- 2007-07-03 CA CA2656549A patent/CA2656549C/fr not_active Expired - Fee Related
- 2007-07-03 AU AU2007270910A patent/AU2007270910B2/en not_active Ceased
- 2007-07-03 WO PCT/HU2007/000059 patent/WO2008004013A2/fr active Application Filing
- 2007-07-03 DK DK07766491.0T patent/DK2049113T3/da active
- 2007-07-03 CN CN2007800306551A patent/CN101516373B/zh not_active Expired - Fee Related
- 2007-07-03 MX MX2009000243A patent/MX2009000243A/es active IP Right Grant
- 2007-07-03 BR BRPI0713395-2A patent/BRPI0713395A2/pt not_active IP Right Cessation
- 2007-07-03 PT PT07766491T patent/PT2049113E/pt unknown
- 2007-07-03 NZ NZ574596A patent/NZ574596A/xx not_active IP Right Cessation
- 2007-07-03 EP EP07766491A patent/EP2049113B8/fr active Active
- 2007-07-03 JP JP2009517450A patent/JP5174018B2/ja not_active Expired - Fee Related
- 2007-07-03 PL PL07766491T patent/PL2049113T3/pl unknown
- 2007-07-03 AT AT07766491T patent/ATE468854T1/de active
- 2007-07-03 US US12/307,385 patent/US8318743B2/en not_active Expired - Fee Related
-
2009
- 2009-01-01 IL IL196315A patent/IL196315A/en not_active IP Right Cessation
- 2009-01-27 MA MA31589A patent/MA30951B1/fr unknown
- 2009-09-11 HK HK09108358.0A patent/HK1131032A1/xx not_active IP Right Cessation
-
2010
- 2010-08-18 CY CY20101100766T patent/CY1110741T1/el unknown
- 2010-08-23 HR HR20100465T patent/HRP20100465T1/hr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA27097A1 (fr) | Aza-arylpiperazines | |
| MA31923B1 (fr) | Composés de 1,2,4-oxadiazole pour le traitement de maladies auto-immunes | |
| TN2009000471A1 (fr) | Composes amino-heterocycliques | |
| MA30412B1 (fr) | Composés Pharmaceutiques | |
| MA29875B1 (fr) | Formule de capsules de pirfenidone et excipients pharmacocompatibles | |
| MA30089B1 (fr) | (arylsulfonyl)-pyrasolopiperidines | |
| JP5058156B2 (ja) | 炎症性腸疾患治療薬 | |
| EP2552902A1 (fr) | Inhibiteurs de transcriptase inverse non nucléosidiques | |
| MA30693B1 (fr) | Derives de la purine utilises en tant qu'agonistes de l'a2a | |
| MA30532B1 (fr) | Sulfonamides tricycliques condenses inhibiteurs de gamma-secretase | |
| NZ593467A (en) | Treatment of cognitive disorders with (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | |
| MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
| MA46268A (fr) | Dérivés de 5-[2-(pyridin-2-ylamino)-1,3-thiazol-5-yl]-2,3-dihydro-1h-isoindol-1-one et leur utilisation en tant qu'inhibiteurs doubles de phosphatidylinositol 3-kinase delta & gamma | |
| WO2002062390A1 (fr) | Compositions pharmaceutiques contre des déficiences urologiques | |
| MA31171B1 (fr) | Hétérocycles bicycliques, agents pharmaceutiques contenant ces composés, leur utilisation et leur procédé de préparation | |
| US20210015809A1 (en) | Iloperidone metabolite for use in the treatment of psychiatric disorders | |
| MA30951B1 (fr) | Medicament pour l'amelioration d'une fonction cognitive et la neuroprotection | |
| MA30308B1 (fr) | Dérivés de benzoisoindole utilisés dans le traitement de la douleur | |
| JP2007517060A (ja) | 中枢神経系障害又は疾患の治療又は管理のためのサリドマイドを用いた方法及び組成物 | |
| JP2009501205A (ja) | 精神病治療用組成物 | |
| CA2431761A1 (fr) | Nouveaux derives de 2,3-benzodiazepine et compositions pharmaceutiques contenant lesdits derives comme matiere active | |
| JP2004161636A (ja) | 軽度認知障害または注意欠陥多動性障害治療剤 | |
| JP2014080396A (ja) | 新規な糖尿病予防及び治療用医薬組成物 |